Change to the Management Board of Carl Zeiss Meditec AG
- Management Board member Jan Willem de Cler to leave the Company at his own request and on good terms.
- The Supervisory Board has agreed to terminate his Management Board contract effective 30 September 2022.
Jena, Germany | 8 September 2022 | Carl Zeiss Meditec AG
Jan Willem de Cler, member of Carl Zeiss Meditec AG’s Management Board, has informed the Supervisory Board that he shall not be available for a further term of office. The Supervisory Board has acknowledged Jan Willem de Cler’s decision with regret and has today agreed to terminate his Management Board contract effective 30 September 2022. Jan Willem de Cler is leaving the Company on good terms.
“The Supervisory Board of Carl Zeiss Meditec AG would like to thank Jan Willem de Cler for his exceptionally high level of commitment and for the major successes he has achieved over his 18 years in a wide range of management roles at ZEISS. He was particularly instrumental in driving forward the ZEISS Medical Technology Segment and our culture,” said Dr. Karl Lamprecht, Chairman of the Supervisory Board of Carl Zeiss Meditec AG. “We wish him all the very best and every success in the future.”
The Company shall announce the future composition of the management team at a later date.
![Jan Willem de Cler]({"small":"https://images.zeiss.com/media/press-photos/products/medical-technology/jan_willem_de_cler_prev.ts-1662635201500.jpg?auto=compress%2Cformat&fm=png&ixlib=java-1.1.11&w=640&s=5bb71a5b537cef5318d76204885e9ec4","large":"https://images.zeiss.com/media/press-photos/products/medical-technology/jan_willem_de_cler_prev.ts-1662635201500.jpg?auto=compress%2Cformat&fm=png&ixlib=java-1.1.11&w=1280&s=51518b7ead340d3001476d7a27235f0f","medium":"https://images.zeiss.com/media/press-photos/products/medical-technology/jan_willem_de_cler_prev.ts-1662635201500.jpg?auto=compress%2Cformat&fm=png&ixlib=java-1.1.11&w=832&s=39517ea9c45f067353432c1f3dfe40be","full":"https://images.zeiss.com/media/press-photos/products/medical-technology/jan_willem_de_cler_prev.ts-1662635201500.jpg?auto=compress%2Cformat&fm=png&ixlib=java-1.1.11&w=1920&s=19c1ef97dc0330eef3c01af5a03a5bbc"} "Jan Willem de Cler")
Jan Willem de Cler (57) has been a member of the Management Board of Carl Zeiss Meditec AG since 2018. He joined ZEISS in 2004 as Managing Director of the Benelux sales company and subsequently also took over the management of the sales company in France and the medical device company France Chirurgie Instrumentation (FCI). In 2010, he was appointed Head of Surgical Ophthalmology at Carl Zeiss Meditec AG, later becoming a member of the Management Board responsible for HR, Global Operations and Service, among others. Prior to his career at ZEISS, he held a number of different positions at General Electric and GE Medical Systems, before co-founding and becoming Sales & Marketing Director of start-up company Global Healthcare Exchange Europe.
